Skip to main content

VROOM trial: Pausing methotrexate doubles antibody response to COVID-19 booster vaccine

Holding methotrexate treatment for 2 weeks following administration of a booster dose of vaccines against SARS-CoV-2 significantly improves the humoral immune response to vaccination, suggest findings from a randomized controlled trial.


Real-world data magnify abemaciclib–thrombosis link in breast cancer

The incidence of thrombosis among people receiving the CDK4/6 inhibitor abemaciclib for metastatic breast cancer is approximately threefold higher in a real-world setting than that observed in clinical trials, US study data show.

Headlines from across medwireNews

06-07-2022 | Diabetes | News | Article

Hybrid closed-loop system brings benefits even with lax bolusing

Use of the Tandem Control IQ hybrid closed-loop insulin delivery system improves time in range even for users who very rarely bolus for meals or to treat hyperglycemia, an observational study suggests.

05-07-2022 | Diabetes | News | Article

Highest CV risk may warrant SGLT2 inhibitor rather than GLP-1 receptor agonist

The rate of heart failure hospitalization rises more than the rate of major adverse cardiovascular events as vascular risk increases in people with type 2 diabetes, report researchers.

05-07-2022 | Rheumatology | News | Article

EMA recommends approval of upadacitinib for nonradiographic axSpA

Click through for more information on this expanded indication

04-07-2022 | Oncology | News | Article

ASCO updates multiple advanced breast cancer guidelines

More information about the three updated clinical practice guidelines here.

04-07-2022 | Rheumatology | News | Article

Ozoralizumab shows promise in methotrexate-resistant RA

The next-generation anti-tumor necrosis factor-alpha antibody ozoralizumab significantly improves clinical signs and symptoms of rheumatoid arthritis relative to placebo in people with active disease despite methotrexate therapy, research suggests.

01-07-2022 | Diabetes | News | Article

Flash monitoring initiation may boost mental health

An observational study suggests that initiating flash glucose monitoring might lead to a reduction in symptoms of depression in people with insulin-treated diabetes.

medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make your preferred medical news resource.

Meet the team